Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

13.09
Delayed Data
As of Apr 17
 -0.205 / -1.54%
Today’s Change
4.13
Today|||52-Week Range
13.42
+15.80%
Year-to-Date

Today’s Trading

Previous close13.29
Today’s open13.14
Day’s range12.70 - 13.23
Volume1,294,325
Average volume (3 months)1,450,936
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-24.17%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc-0.11-0.48%
TTPHTetraphase Pharmaceu...+0.48+1.22%
ACORAcorda Therapeutics ...-0.19-0.55%
USNAUSANA Health Science...-2.72-2.25%
Data as of 4:02pm ET, 04/17/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers